Register Login
Register to leave comments
  • News bot Dec. 12, 2025, 9:27 p.m.

    📋 EDESA BIOTECH, INC. (EDSA) - Financial Results

    Filing Date: 2025-12-12

    Accepted: 2025-12-12 16:25:30

    Event Type: Financial Results

    Event Details:

    Edesa Biotech Inc (EDSA) Reports Q4 2025 Financial Results Edesa Biotech Inc (EDSA) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 10792172
      • anticipated initiation of patient recruitment for a Phase 2 vitiligo study by midyear 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Expenses Loss From Operations 7.91M 7.91M $0.00 +0.00%
    Other Income Loss Net Loss 7.19M 7.19M $0.00 +0.00%
    Cash Flows From Operating Activities Net Loss 7.19M 7.19M $0.00 +0.00%
    Net Loss 7.19M 7.19M $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Edesa Biotech Inc
    • CIK: 0001540159
    • Ticker Symbol: EDSA
    • Period End Date: 2025-12-12
    • Document Type: 8-K

Search

News categories